摘要
政府对新药的限价过低将会抑制药品的研发投入,价格过高又必然会损害患者的效用。文章通过模型分析,认为在政府有能力对新药进行合理定价的情况下,存在政府定价与药品研发投入的纳什均衡。应用限价策略,不仅能为政府审查药品的价格提供参考、能为政府对新药限价提供依据,而且有助于保证药企研发投入的合理水平。
The government limit too low on new drugs price will curb investment in research and development of drugs, and too high price will inevitably damage the effectiveness of the patients. The model analysis that, if the government has the capable to make reasonable price of new drug, then there has the investment Nash equilibrium between government pricing and drug research and development. Application the drug price limit strategy, not only make reference for the government to review the price of drugs, but also provide a reference for the Government to limit new drugs price, and helps to ensure a reasonable level of investment in new drug research and development of pharmaceutical companies.
基金
国家自然科学基金(71273175)
上海市公共卫生重点学科建设项目(12GWZX0601)
关键词
药品研发投入
政府限价
纳什均衡
pharmaceutical research and development investment
government price
Nash equilibrium
